本页面由Tiger Trade Technology Pte. Ltd.提供服务

Enlivex Therapeutics Ltd.

0.8886
+0.06868.37%
盘后0.8700-0.0186-2.09%19:00 EDT
成交量:180.29万
成交额:154.75万
市值:2.11亿
市盈率:0.03
高:0.8982
开:0.8196
低:0.8000
收:0.8200
52周最高:2.10
52周最低:0.6600
股本:2.37亿
流通股本:2.35亿
量比:2.71
换手率:0.77%
股息:- -
股息率:- -
每股收益(TTM):25.48
每股收益(LYR):25.48
净资产收益率:126.17%
总资产收益率:-0.80%
市净率:0.11
市盈率(LYR):0.03

数据加载中...

2019/06/19

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/05/31

超过5%披露

General statement of acquisition of beneficial ownership
2019/05/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/07/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/04/23

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2018/04/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2017/12/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]